Xilio Therapeutics, Inc.
NASDAQ:XLO · NASDAQ Global Select
+$0.32 today
Vol 0.04M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-8.97%
Period High
$12.08
Period Low
$7.14
Latest
$8.48
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
PDS Biotechnology Corporation
NASDAQ:PDSB
$58.61M
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$57.43M
Kezar Life Sciences, Inc.
KZR
$53.86M
LAVA Therapeutics N.V.
LVTX
$45.77M
FibroGen, Inc.
FGEN
$36.69M
Aligos Therapeutics, Inc.
ALGS
$32.67M
Actinium Pharmaceuticals, Inc.
ATNM
$31.69M
Skye Bioscience, Inc.
SKYE
$27.67M
Tvardi Therapeutics, Inc.
TVRD
$24.77M
Tempest Therapeutics, Inc.
TPST
$5.60M
What is the latest XLO filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does XLO have?
Intrinsic Alpha currently shows 20 recent filings for XLO.
Explore More
Continue the stock analysis
Jump to another research area for this company.